E Fund Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
6,442
-65,118
| -91% | -$6.99M | 0.03% | 198 |
|
|
2025
Q1 | $7.22M | Sell |
71,560
-15,288
| -18% | -$1.54M | 0.34% | 46 |
|
|
2024
Q4 | $7.76M | Buy |
86,848
+33,274
| +62% | +$2.97M | 0.39% | 36 |
|
|
2024
Q3 | $4.49M | Buy |
53,574
+49,164
| +1,115% | +$4.12M | 0.23% | 44 |
|
|
2024
Q2 | $340K | Sell |
4,410
-413
| -9% | -$31.8K | 0.02% | 218 |
|
|
2024
Q1 | $330K | Buy |
4,823
+216
| +5% | +$14.8K | 0.02% | 265 |
|
|
2023
Q4 | $266K | Buy |
4,607
+683
| +17% | +$39.5K | 0.02% | 248 |
|
|
2023
Q3 | $207K | Sell |
3,924
-302
| -7% | -$15.9K | 0.02% | 252 |
|
|
2023
Q2 | $229K | Sell |
4,226
-517
| -11% | -$28K | 0.02% | 262 |
|
|
2023
Q1 | $237K | Sell |
4,743
-327
| -6% | -$16.3K | 0.02% | 267 |
|
|
2022
Q4 | $235K | Sell |
5,070
-805
| -14% | -$37.3K | 0.02% | 273 |
|
|
2022
Q3 | $228K | Buy |
5,875
+382
| +7% | +$14.8K | 0.02% | 280 |
|
|
2022
Q2 | $205K | Buy |
5,493
+134
| +3% | +$5K | 0.02% | 295 |
|
|
2022
Q1 | $237K | Sell |
5,359
-766
| -13% | -$33.9K | 0.01% | 264 |
|
|
2021
Q4 | $260K | Buy |
6,125
+141
| +2% | +$5.99K | 0.01% | 226 |
|
|
2021
Q3 | $260K | Buy |
+5,984
| New | +$260K | 0.01% | 202 |
|